Plasma Versus Whole Blood Tacrolimus Concentrations and Health-Related Quality of Life in Kidney Transplant Recipients
<b>Background/Objectives</b>: Tacrolimus dosing traditionally relies on therapeutic drug monitoring in whole blood, while assessment in plasma may better reflect its effect and reveal overdosing impacting health-related quality of life (HRQoL). <b>Methods</b>: In this cross-s...
Saved in:
| Main Authors: | Svea Nolte, J. Casper Swarte, Tim J. Knobbe, Ilja M. Nolte, Tanja R. Zijp, Harmen R. Moes, Marco van Londen, Niels L. Riemersma, Johannes R. Björk, Rinse K. Weersma, Gea Drost, Stefan P. Berger, Daan J. Touw, Stephan J. L. Bakker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/5/590 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intrapatient tacrolimus variability is associated with medical nonadherence among pediatric kidney transplant recipients
by: Tara B. Gavcovich, et al.
Published: (2025-03-01) -
Conversion from Extended-Dose-Release Tacrolimus to Melt-Dose Tacrolimus in High Metabolizer Patients: Is the New Formulation of LPCT the Best Option for High Metabolizer Kidney Transplanted Patients?
by: Paolo Carta, et al.
Published: (2020-05-01) -
Impact of CYP3A5 1* and 3* single nucleotide variants on tacrolimus pharmacokinetics and graft rejection risk in pediatric kidney transplant patients
by: Lesly Yanira Xajil-Ramos, et al.
Published: (2025-05-01) -
An Uncommon Neurological Complication of Tacrolimus: Foot Drop
by: Vijay Chander Bukka, et al.
Published: (2025-01-01) -
Tacrolimus for Ophthalmic Use: An Update
by: Sana Ilias Tinwala, et al.
Published: (2013-01-01)